How to Avoid Common Pitfalls in Roll-Ups: Notes from the Deal Table
Private Equity (PE) investment activity, particularly in Mergers and Acquisitions (M&A), has become a powerhouse for fast upsized returns in recent years. Roll-ups — where multiple smaller companies are combined into a larger entity — promise greater scale, stronger purchasing power, and more streamlined reporting. In many cases they deliver exactly that.
In others, value erodes for reasons that don't appear in the model or the valuation tables, but do appear in customer experience and long-term sustainability.
Think Toys R' Us and Red Lobster.
In the medical aesthetics industry, words like efficiency and experience are often treated as trade-offs. They are not. Precision in process can coexist with compassion in care when the right strategies are in place.
1) The "Single Playbook" Problem
Standardization can reduce cost and complexity. Applied too early or too broadly, it removes the features that made a business successful in the first place. Local reputation, personalized experiences, pricing or marketing towards specific demographics — these are features, not bugs.
The fix: Build a framework, not a formula. Core systems (technology, reporting, compliance) should be standardized. Patient experience and clinical identity should remain locally driven.
2) Founder Misalignment Post-Close
Many roll-ups win the deal but lose the founder. If the original owner disengages — emotionally, operationally, or relationally — the clinic loses the trust equity they spent years building.
Staff morale drops. Patient relationships erode. Culture shifts.
The fix: Structure earnouts and post-acquisition roles that keep founders engaged and aligned. Don't buy their clinic and then make them feel like employees. They were the engine. Keep them that way.
3) Speed Over Culture
Roll-ups move fast. That speed is part of their thesis — acquire quickly, integrate quickly, realize synergies quickly. But integration speed that outpaces cultural readiness destroys value.
Staff who don't understand why things are changing become resistant. Managers who feel bypassed disengage. Patients who notice the shift in energy quietly leave.
The fix: Invest the first 90 days in listening. Integration plans should be shaped by what you find, not just what you assumed before the deal.
4) Underestimating Clinical Dependency
In aesthetics, one or two key clinicians often represent 60–80% of revenue. Lose them post-acquisition and you've lost the asset you paid for.
The fix: Clinical retention is part of the deal, not a post-close afterthought. Build it into the structure. Multi-year retention packages, equity participation, genuine partnership — not just employment contracts.
5) Reporting Without Rhythm
Roll-ups often impose reporting structures before the acquired business has the systems to support them. The result: distorted data, overwhelmed managers, and poor decisions based on incomplete information.
The fix: Invest in systems before demanding outputs. Build the dashboard before demanding the numbers. Give clinic operators tools, not just templates.
The Northwyn Approach
We believe roll-ups fail not because the thesis is wrong, but because execution misses the human layer.
Our model is built on four commitments:
Founder-first deal structures — you remain central, not peripheral
Integration at the pace of trust — we move at the speed of relationship
Platform support, not platform imposition — we enable, not override
Long-term alignment — our returns are tied to your growth, not just our exit
<